Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NELVUTAMIG: Who Reports Side Effects? Age, Gender & Country Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Gender Distribution

41.0%
Female
59.0%
Male

Age Information

The average age of patients reporting adverse events with NELVUTAMIG is 59.8 years.

Geographic Distribution

The majority of adverse event reports for NELVUTAMIG originate from EU.

Report Summary & Outcomes

277
Total Reports
277
As Primary/Secondary Suspect
34
Deaths Reported
109
Hospitalizations
36
Life-Threatening
5
Disabilities

Reporting Timeline

First adverse event report: 20180923. Most recent report: 20250828. View full timeline →

More About NELVUTAMIG

NELVUTAMIG Full Profile Reports by Year Drug Interactions